CLINICAL_TRIALS
trial_result
· 2016-08-10
Clinical Trial Update: Antiproteinuric Effects of Liraglutide Treatment [Phase 4]
Summary
Phase 4 trial update on antiproteinuric effects of liraglutide in diabetic kidney disease, with the study status noted as completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Steno Diabetes Center Copenhagen | Conditions: Diabetic Kidney Disease | Phase 4 | Status: COMPLETED